feed,title,long_url,short_url
Benzinga,"Bluebird bio Seeks Back-to-Back Nods, 'Go' or 'No-Go' For Revance's Botox Rival, Amylyx' Twin Hurdles And More: September's Key PDUFA Catalysts Biotech Investors Must Know",https://benzinga.com/general/biotech/22/08/28705100/bluebird-bio-seeks-back-to-back-nods-go-or-no-go-for-revances-botox-rival-amylyx-twin-hurdles-and,https://bit.ly/3Az01lL
